Systematic Financial Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-71,000
| Closed | -$1.1M | – | 670 |
|
|
2018
Q4 | $1.1M | Sell |
71,000
-242,868
| -77% | -$3.75M | 0.03% | 429 |
|
|
2018
Q3 | $6.76M | Buy |
313,868
+124,983
| +66% | +$2.69M | 0.16% | 203 |
|
|
2018
Q2 | $4.59M | Buy |
+188,885
| New | +$4.59M | 0.11% | 229 |
|
|
2016
Q4 | – | Sell |
-199,567
| Closed | -$9.18M | – | 667 |
|
|
2016
Q3 | $9.18M | Sell |
199,567
-5,748
| -3% | -$264K | 0.13% | 198 |
|
|
2016
Q2 | $10.3M | Sell |
205,315
-36,670
| -15% | -$1.84M | 0.14% | 176 |
|
|
2016
Q1 | $12.9M | Sell |
241,985
-7,901
| -3% | -$423K | 0.16% | 154 |
|
|
2015
Q4 | $16.4M | Sell |
249,886
-6,012
| -2% | -$395K | 0.18% | 111 |
|
|
2015
Q3 | $14.4M | Sell |
255,898
-193,769
| -43% | -$10.9M | 0.15% | 139 |
|
|
2015
Q2 | $26.6M | Sell |
449,667
-65,990
| -13% | -$3.9M | 0.23% | 116 |
|
|
2015
Q1 | $32.1M | Sell |
515,657
-31,997
| -6% | -$1.99M | 0.25% | 110 |
|
|
2014
Q4 | $31.5M | Buy |
547,654
+40,498
| +8% | +$2.33M | 0.23% | 108 |
|
|
2014
Q3 | $27.3M | Sell |
507,156
-10,449
| -2% | -$562K | 0.2% | 123 |
|
|
2014
Q2 | $27.1M | Buy |
517,605
+15,271
| +3% | +$800K | 0.19% | 129 |
|
|
2014
Q1 | $26.5M | Buy |
502,334
+485,664
| +2,913% | +$25.7M | 0.18% | 138 |
|
|
2013
Q4 | $668K | Sell |
16,670
-3,300
| -17% | -$132K | ﹤0.01% | 604 |
|
|
2013
Q3 | $754K | Hold |
19,970
| – | – | 0.01% | 597 |
|
|
2013
Q2 | $782K | Buy |
+19,970
| New | +$782K | 0.01% | 588 |
|